Abstract

BackgroundChinese hamster ovary (CHO) cells have become the host of choice for the production of recombinant proteins, due to their capacity for correct protein folding, assembly, and posttranslational modifications. The most widely used system for recombinant proteins is the gene amplification procedure that uses the CHO-Dhfr expression system. However, CHO cells are known to have a very unstable karyotype. This is due to chromosome rearrangements that can arise from translocations and homologous recombination, especially when cells with the CHO-Dhfr expression system are treated with methotrexate hydrate. The present method used in the industry for testing clones for their long-term stability of recombinant protein production is empirical, and it involves their cultivation over extended periods of time prior to the selection of the most suitable clone for further bioprocess development. The aim of the present study was the identification of marker genes that can predict stable expression of recombinant genes in particular clones early in the development stage.ResultsThe transcriptome profiles of CHO clones with stable and unstable recombinant protein production were investigated over 10-weeks of cultivation, using a DNA microarray. We identified 14 genes that were differentially expressed between the stable and unstable clones already at 2 weeks from the beginning of the cultivation. Their expression was validated by reverse-transcription quantitative real-time PCR (RT-qPCR). Furthermore, the k-nearest neighbour algorithm approach shows that the combination of the gene expression patterns of only five of these 14 genes is sufficient to predict stable recombinant protein production in clones in the early phases of cell-line development.ConclusionsThe exact molecular mechanisms that cause unstable recombinant protein production are not fully understood. However, the expression profiles of some genes in clones with stable and unstable recombinant protein production allow prediction of such instability early in the cell-line development stage. We have thus developed a proof-of-concept for a novel approach to eliminate unstable clones in the CHO-Dhfr expression system, which saves time and labour-intensive work in cell-line development.Electronic supplementary materialThe online version of this article (doi:10.1186/s12896-015-0218-9) contains supplementary material, which is available to authorized users.

Highlights

  • IntroductionChinese hamster ovary (CHO) cells have become the host of choice for the production of recombinant proteins, due to their capacity for correct protein folding, assembly, and posttranslational modifications

  • Chinese hamster ovary (CHO) cells have become the host of choice for recombinant protein production, due to their capacity for correct protein folding, assembly and posttranslational modification

  • CHO cells are known to have a very unstable karyotype, due to chromosome rearrangements that can arise from translocations and homologous recombination, especially when amplified with methotrexate hydrate (MTX) [4, 5]

Read more

Summary

Introduction

Chinese hamster ovary (CHO) cells have become the host of choice for the production of recombinant proteins, due to their capacity for correct protein folding, assembly, and posttranslational modifications. CHO cells are known to have a very unstable karyotype, due to chromosome rearrangements that can arise from translocations and homologous recombination, especially when amplified with methotrexate hydrate (MTX) [4, 5]. In this context, unstable recombinant protein production has been observed in 8 to 63 % of all recombinant CHO (rCHO) cell lines using CHO-Dhfr/ glutamine synthetase expression systems in the absence and presence of selection pressure (MTX) [6,7,8]. Some productivity oriented studies have included transcriptomics and/or proteomic studies [17,18,19,20,21,22]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.